… Follicular lymphoma (FL) is the second most frequent NHL subtype. Patients who relapse …
R/R FL and were often durable. Here, we report the incidence and durability of responses in …

… durable remission and cure, the sequential application of effective, non-cross-resistant treat…
It is essential that physicians treating patients with follicular lymphoma demonstrate restraint …

… ASCT, however, retains its role as a therapeutic option in the relapse setting where long-lasting
remissions can be achieved. Whether and when ASCT should be applied, that is, at first, …

… Complicating matters is a lack of robust end points to know … of disease, and achieving durable
disease control. We consider … On the basis of his young age and short remission duration, …

… In conclusion, ASCT is associated with high rates of durable remissions in relapsed FL,
with long-term follow-up confirming that more than 50% of transplanted patients may be …

… transplants in patients with follicular lymphoma (FL) remains … remission versus those
transplanted in later remissions (P = 0… transplanted in either first or second remissions after 9·3 …

… Furthermore, our results support the role of ASCT as consolidation therapy at first chemosensitive
relapse/progression for FL patients providing long term durable remissions in a subset …

… more durable remissions than moderate regimens in advanced stage low-grade lymphoma,…
be curative for some patients with stage III follicular lymphoma.,9 The rationale for extensive …

… In some patients, the disease exhibits transformation or aggressive and chemotherapy-resistant
behaviour, whereas in others the disease is indolent with durable remissions after …

… (FL) is the most common indolent non-Hodgkin lymphoma (NHL), accounting for ∼… Lymphoma
Group (NLG) demonstrated that rituximab monotherapy can produce durable remissions …